- Investor's Business Daily•11 hours ago
Momenta and Pfizer are unexpectedly giving Teva some breathing room on a generic version of MS drug Copaxone.
- Motley Fool•11 hours ago
The drugmaker announced a delay to approval of its three-times-weekly version of Glatopa.
- Investopedia•14 hours ago
Teva is up this morning, after Momenta Pharmaceuticals announced a delay of its generic version of Copaxone.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||36.10 - 37.94|
|52 Week Range||31.90 - 59.35|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.32|
|Dividend & Yield||1.36 (3.86%)|
|1y Target Est||N/A|